PNC-27
$150.00
- PNC-27 has been shown to be an Anti-cancer peptides (ACPs) are a series of short peptides composed of PNC-27, that can inhibit tumor cell proliferation or migration, or suppress the formation of tumor blood vessels, and are less likely to cause drug resistance.
- PNC-28 is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to investigate selective apoptotic mechanisms in malignant cell models. This peptide functions by interacting with mitochondrial membranes in transformed cell populations, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.
- PNC-28 plays an important role in research examining apoptotic signaling pathways, p53-mediated stress responses, and differential cytotoxicity in neoplastic versus non-neoplastic cells. It has shown potential in modulating oncogenic processes in vitro, contributing to investigations of tumor suppression and cellular homeostasis.
- In addition to its observed cytotoxic properties in malignant models, PNC-28 may support further research into tumor immunogenicity and immune system interactions with transformed cells. PNC-28 offers a valuable compound for exploring experimental approaches related to oncology, apoptosis regulation, and cancer peptide research.
Overview
Aurex PNC-27 is a research peptide recognized for its potential to target and eliminate cancer cells while sparing healthy tissue. It works by disrupting the membranes of cancer cells, promoting apoptosis. This peptide is being studied for its ability to enhance the effectiveness of conventional cancer treatments, presenting a promising avenue for non-invasive cancer therapy.
Key Features & Benefits
-
Selective Cancer Targeting: PNC-27 is designed to selectively target and induce apoptosis in cancerous cells, offering a novel approach to studying tumor-specific treatments.
-
Mechanism of Action: Interacts directly with cancer cell membranes to trigger cell death, providing insights into developing therapies that minimize harm to healthy cells.
-
Anti-Cancer Peptide: Known for its potential to inhibit tumor cell proliferation and migration, PNC-27 plays a significant role in cancer research focused on peptide-based interventions.
-
High-Purity Formulation: Each vial contains a precise amount of PNC-27, with ≥ 99% purity (HPLC verified) to ensure reliable and consistent research outcomes.
Primary Research Applications
-
Cancer Cell Apoptosis Studies: Used in research examining mechanisms of tumor cell death and the potential therapeutic application of peptide-induced apoptosis.
-
Tumor Suppression Research: Investigations into PNC-27’s role in modulating oncogenic processes and tumor growth suppression.
-
Comparative Analysis: Allows for analysis of peptide efficacy versus traditional cancer therapies in preclinical models.
Product Specifications
- Unit Size: 10mg
-
Compound: PNC-27
-
Purity: ≥ 99% purity (HPLC verified) for assured consistency in research results
-
Quantity: Provided in research-grade amounts per vial for experimental flexibility
-
Form: Lyophilized (freeze-dried) powder for stability and convenience in laboratory settings
-
Storage: Store in a cool, dry place. For long-term stability, refrigeration is recommended.
Important Notice
This blended product is for chemical and laboratory research purposes only. It is not for human or veterinary consumption. The synergistic effects are potent, and this product should only be handled by qualified researchers in a controlled setting.
Reviews
There are no reviews yet.